A detailed history of Janus Henderson Group PLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 21,900 shares of CDNA stock, worth $527,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,900
Holding current value
$527,133
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $315,579 - $744,381
21,900 New
21,900 $683,000
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $35 - $56
5 Added 0.02%
23,653 $165,000
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $243 - $302
-32 Reduced 0.14%
23,648 $201,000
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $116,105 - $231,553
13,149 Added 124.86%
23,680 $216,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $305 - $501
19 Added 0.18%
10,531 $180,000
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $266 - $516
-13 Reduced 0.12%
10,512 $226,000
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $56 - $93
2 Added 0.02%
10,525 $389,000
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $218,112 - $389,638
5,294 Added 101.24%
10,523 $479,000
Q3 2021

Nov 16, 2021

BUY
$59.15 - $91.99 $309,295 - $481,015
5,229 New
5,229 $331,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.29B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.